The human immune deficiency virus (HIV) first entered public consciousness in the early 1980s, after cases of unfamiliar and ...

University of Utah Health announced Friday the development of a promising new HIV drug. The drug, lenacapavir, has been named ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept ...

Researchers have announced that a 53-year-old man in Germany is the fifth person to be cured of HIV through a stem cell ...

Over 800 million people have genital herpes — and in many cases the virus can flare up over a person's lifetime, causing ...

“Sundquist’s research focuses on understanding how the virus is built ... the nucleus of host cells. “Lenacapavir phase three clinical trials for the prevention of HIV transmission have ...

Yesterday, 38 leading biologists joined together to issue a warning about the fascinating yet terrifying new technology ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...